Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with pancreatic cancer confirmed by a laboratory test of tissue or cell samples
- People whose general health and ability to carry out daily activities meets a certain minimum level (a doctor will assess this using a standard scale called the ECOG scale, with a score of 2 or lower required)
- People whose cancer has been identified through scans as locally advanced pancreatic cancer, based on standard medical guidelines
- People who have not yet received any treatment for their cancer
- People who are willing and able to sign a written consent form to participate
Who may not be able to join:
- People who have previously received any type of cancer treatment
- People who have a serious active infection above a certain severity level (a doctor will assess this)
- People who have an autoimmune disease or a weakened immune system and are currently taking medicines that suppress the immune system
- People who have a tendency to bleed or bleeding-related conditions
- People who are pregnant or currently breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Juan Du, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phone: +86-025-83106666
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
mPFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.